Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Abbott Laboratories

    Market Cap (Aug-2026)
    192.505 Billion USD
    World Rank (Jan-05-2024)
    57
    Market Cap (Jan-05-2024)
    192.668 Billion USD
    World Rank (Jul-30-2023)
    57
    Market Cap (Jul-30-2023)
    196.030 Billion USD
    World Rank (Dec-25-2022)
    51
    Market Cap (Dec-25-2022)
    188.620 Billion USD
    World Rank (Jan-07-2022)
    43
    Market Cap (Jan-07-2022)
    239.71 Billion USD
    Annual Revenue in USD
    44,328 Million USD
    Annual Operating Income in USD
    8,053 Million USD
    Annual Net Income in USD
    6,524 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Abbott Laboratories is USA based healthcare and pharmaceutical and is multi-national company. Abbott has presence in more than 150 countries. Key working areas of Abbott are related to Diabetes, Diagnostics, Neuro Modulation, Nutrition, Pharmaceuticals. They have over 113,000 employees as on 2021. Headquarters is in USA.

    Facts About Company

    As on 2022, Abbott Laboratories has 115,000 employees.

    Abbott Laboratories annual revenue generated for period ending Dec-2022 was 43,653 million USD.

    Abbott Laboratories annual net income generated for period ending Dec-2022 was 6,933 million USD.

    Abbott Laboratories annual revenue generated for period ending Dec-2021 was 43,075 million USD.

    Abbott Laboratories annual net income generated for period ending Dec-2021 was 7,071 million USD.

    Total Assets as on Dec-2021 was 75,196 Million USD.

  2. Gilead Sciences

    Market Cap (Aug-2026)
    171.560 Billion USD
    World Rank (Jan-05-2024)
    133
    Market Cap (Jan-05-2024)
    105.265 Billion USD
    World Rank (Jul-30-2023)
    154
    Market Cap (Jul-30-2023)
    95.871 Billion USD
    World Rank (Dec-25-2022)
    120
    Market Cap (Dec-25-2022)
    106.300 Billion USD
    World Rank (Jan-07-2022)
    180
    Market Cap (Jan-07-2022)
    89.39 Billion USD
    Annual Revenue in USD
    29,443 Million USD
    Annual Operating Income in USD
    10,022 Million USD
    Annual Net Income in USD
    8,510 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    GILEAD SCIENCES INC is world’s largest bio-pharmaceutical companies. As on Dec-2021, Gilead Sciences had 14,400 employees across six continents and headquarters is in USA,

    As on 2022, GILEAD SCIENCES INC has 17,000 employees.

    GILEAD SCIENCES INC annual revenue generated for period ending Dec-2022 was 27,281 million USD.

    GILEAD SCIENCES INC annual net loss generated for period ending Dec-2022 was 4,592 million USD.

  3. Pfizer

    Market Cap (Aug-2026)
    152.694 Billion USD
    World Rank (Jan-05-2024)
    67
    Market Cap (Jan-05-2024)
    167.868 Billion USD
    World Rank (Jul-30-2023)
    53
    Market Cap (Jul-30-2023)
    203.630 Billion USD
    World Rank (Dec-25-2022)
    28
    Market Cap (Dec-25-2022)
    290.940 Billion USD
    World Rank (Jan-07-2022)
    27
    Market Cap (Jan-07-2022)
    312.75 Billion USD
    Annual Revenue in USD
    62,579 Million USD
    Annual Operating Income in USD
    7,520 Million USD
    Annual Net Income in USD
    7,771 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world and their products are pharmaceutical drugs, vaccines.

    Facts About Company

    As of 2022, Pfizer has 83,000 employees.

    Pfizer annual revenue generated for period ending Dec-2022 was 100.33 billion USD.

    Pfizer annual net income generated for period ending Dec-2022 was 31.37 billion USD.

    As of 2021, Pfizer has 79,000 employees.

    Pfizer annual revenue generated for period ending Dec-2021 was 81.28 million USD.

    Pfizer annual net income generated for period ending Dec-2021 was 21.98 million USD.

  4. Bristol-Myers Squibb Company

    Market Cap (Aug-2026)
    130.386 Billion USD
    World Rank (Jan-05-2024)
    130
    Market Cap (Jan-05-2024)
    106.418 Billion USD
    World Rank (Jul-30-2023)
    100
    Market Cap (Jul-30-2023)
    129.010 Billion USD
    World Rank (Dec-25-2022)
    66
    Market Cap (Dec-25-2022)
    154.980 Billion USD
    World Rank (Jan-07-2022)
    96
    Market Cap (Jan-07-2022)
    139.46 Billion USD
    Annual Revenue in USD
    48,194 Million USD
    Annual Operating Income in USD
    10,002 Million USD
    Annual Net Income in USD
    7,055 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

    BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

    Company has over 32,200 employees as on 2021. Headquarters is in USA.

    BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

    BMS be the biopharma company that transforms patients' lives through science.

    Facts About Company

    As on 2022, Bristol-Myers Squibb has 34,300 employees.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2022 was 46,159 million USD.

    Bristol-Myers Squibb annual net income generated for period ending Dec-2022 was 6,327 million USD.

    As on 2021, BMS had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2021 was 46,385 million USD.

  5. Vertex Pharmaceuticals

    Market Cap (Aug-2026)
    128.188 Billion USD
    World Rank (Jan-05-2024)
    129
    Market Cap (Jan-05-2024)
    107.235 Billion USD
    World Rank (Jul-30-2023)
    161
    Market Cap (Jul-30-2023)
    91.186 Billion USD
    World Rank (Dec-25-2022)
    182
    Market Cap (Dec-25-2022)
    74.361 Billion USD
    World Rank (Jan-07-2022)
    323
    Market Cap (Jan-07-2022)
    56.41 Billion USD
    Annual Revenue in USD
    12,001 Million USD
    Annual Operating Income in USD
    4,173 Million USD
    Annual Net Income in USD
    3,953 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    VERTEX PHARMACEUTICALS is USA Based Bio-Technology, Bio-Pharmaceutical and Healthcare Company.It have research and development sites, manufacturing facilities and offices around the world. The company locations are North America, Europe, Australia, South America.

    As on 2022, VERTEX PHARMACEUTICALS has 4,500 employees.

    VERTEX PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 8,930 million USD.

  6. Sanofi

    Market Cap (Aug-2026)
    109.863 Billion USD
    World Rank (Jan-05-2024)
    104
    Market Cap (Jan-05-2024)
    127.146 Billion USD
    World Rank (Jul-30-2023)
    97
    Market Cap (Jul-30-2023)
    130.890 Billion USD
    World Rank (Dec-25-2022)
    102
    Market Cap (Dec-25-2022)
    121.650 Billion USD
    World Rank (Jan-07-2022)
    116
    Market Cap (Jan-07-2022)
    126.37 Billion USD
    Annual Revenue in USD
    50,044 Million USD
    Annual Operating Income in USD
    13,099 Million USD
    Annual Net Income in USD
    7,409 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Sanofi is France based Multi-National Pharmacy company headquartered in Paris, France.

    Sanofi has 32 manufacturing sites in 32 countries. Sanofi provides healthcare solutions in more than 170 countries.

    Sanofi is listed in Paris (Euronext: SAN) and New York (Nasdaq: SNY).

    Facts About Company

    As on 2022, Sanofi had 91,573 employees across 100 countries.

    For year ending Dec-2022, Sanofi annual revenue was 45,389 million EUR and annual net income was 8,371 million EUR during the same period.

    As on 2022, Sanofi had 59 manufacturing sites and 20 R&D sites.

    Sanofi annual revenue for year ending Dec-2022 by Geographical Regions:

  7. McKesson Corporation

    Market Cap (Aug-2026)
    101.317 Billion USD
    World Rank (Jan-05-2024)
    261
    Market Cap (Jan-05-2024)
    63.915 Billion USD
    World Rank (Jul-30-2023)
    312
    Market Cap (Jul-30-2023)
    54.597 Billion USD
    World Rank (Dec-25-2022)
    271
    Market Cap (Dec-25-2022)
    54.402 Billion USD
    World Rank (Jan-07-2022)
    535
    Market Cap (Jan-07-2022)
    38.13 Billion USD
    Annual Revenue in USD
    403,430 Million USD
    Annual Operating Income in USD
    6,212 Million USD
    Annual Net Income in USD
    4,762 Million USD
    Annual Results for Period Ending
    Mar-2026 ending year
    Headquarters Country
    Stock Category
    Company Profile

    McKesson is the oldest and largest healthcare company in the nation, serving more than 50% of U.S. hospitals and 20% of physicians. They deliver one-third of all medications used daily in North America with operations in more than 16 countries. Company has more than 2000 pharmacies. Headquarters is in New York, USA.

    As on 2022, McKesson has 75,000 employees.

    McKesson annual revenue generated for period ending Mar-2022 was 263,966 million USD.

  8. GSK plc

    Market Cap (Aug-2026)
    100.284 Billion USD
    World Rank (Jan-05-2024)
    179
    Market Cap (Jan-05-2024)
    80.265 Billion USD
    World Rank (Jul-30-2023)
    212
    Market Cap (Jul-30-2023)
    72.563 Billion USD
    World Rank (Dec-25-2022)
    185
    Market Cap (Dec-25-2022)
    72.099 Billion USD
    World Rank (Jan-07-2022)
    132
    Market Cap (Jan-07-2022)
    110.32 Billion USD
    Annual Revenue in USD
    37,666 Million USD
    Annual Operating Income in USD
    8,263 Million USD
    Annual Net Income in USD
    19,211 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    GLAXOSMITHKLINE is UK based multi-national Pharmaceuticals business and it has a broad portfolio of innovative and established medicines. GSK currently focus on developing new medicines in respiratory, HIV, oncology and immuno-inflammation; with an R&D approach focused on science related to the immune system, use of genetics and advanced technologies. Headquarters is in UK.

    In 2021 GSK delivered 1.7 billion medicines, over 767 million vaccines* and 3.7 billion consumer healthcare products.

    Facts About Company

    GSK annual revenue was 29,324 Million GBP and annual net income was 14,956 Million GBP for year ending Dec-2022.

    GSK annual revenues for year ending Dec-2021 was 34,144 million GBP and annual operating income was 6,165 million GBP and annual net income of 4,385 million GBP.

    GSK had 70,000 employees as on 2022.

    As on 2021, GSK has over 90,000 employees across 92 countries and work directly with 37,500 suppliers.

  9. Regeneron Pharmaceuticals

    Market Cap (Aug-2026)
    82.722 Billion USD
    World Rank (Jan-05-2024)
    144
    Market Cap (Jan-05-2024)
    100.011 Billion USD
    World Rank (Jul-30-2023)
    174
    Market Cap (Jul-30-2023)
    81.855 Billion USD
    World Rank (Dec-25-2022)
    166
    Market Cap (Dec-25-2022)
    79.143 Billion USD
    World Rank (Jan-07-2022)
    279
    Market Cap (Jan-07-2022)
    64.93 Billion USD
    Annual Revenue in USD
    14,343 Million USD
    Annual Operating Income in USD
    3,578 Million USD
    Annual Net Income in USD
    4,505 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    REGENERON PHARMACEUTICALS is Bio-Pharmaceutical company with headquarters is in New York, USA.

    As on 2022, REGENERON PHARMACEUTICALS has 11,851 employees.

    Facts About Company

    REGENERON PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 12,172 million USD.

    REGENERON PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 4,338 million USD.

    As on 2022, they had 11,851 employees. They had 7 FDA approved medicines.

  10. Japan Tobacco

    Market Cap (Aug-2026)
    79.862 Billion USD
    World Rank (Jan-05-2024)
    381
    Market Cap (Jan-05-2024)
    45.943 Billion USD
    World Rank (Jul-30-2023)
    465
    Market Cap (Jul-30-2023)
    38.941 Billion USD
    World Rank (Dec-25-2022)
    433
    Market Cap (Dec-25-2022)
    37.991 Billion USD
    World Rank (Jan-07-2022)
    579
    Market Cap (Jan-07-2022)
    35.81 Billion USD
    Annual Revenue in USD
    18,828 Million USD
    Annual Operating Income in USD
    4,573 Million USD
    Annual Net Income in USD
    3,136 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    JAPAN TOBACCO manufactures Cigarettes and Tobacco related products manufacturing company with headquarters is in Tokyo, Japan.

    It also has businesses in manufacturing of pharmaceuticals and processed food products.

Share

Ads